Global and China Point of Care Test Market Size, Status and Forecast 2021-2027

Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-of-Care tests have immense potential to improve global health, and to eventually reduce public and national spending on health.

Market Analysis and Insights: Global Point of Care Test Market
The global Point of Care Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point of Care Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point of Care Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point of Care Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point of Care Test market.

Global Point of Care Test Scope and Market Size
Point of Care Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Others

Segment by Application
Clinics
Hospitals
Laboratory
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Trinity Biotech
ELITech Group
Response Biomedical
Princeton BioMeditech
Alfa Wassermann

Frequently Asked Questions